Meghan McCarthy: Closing the Diagnostic Gap in Women with Bleeding Disorders
Meghan McCarthy, Founder of Maternie and MKMV Consulting, shared a post on LinkedIn:
“A Lancet Haematology Commission published findings on the diagnosis gap for bleeding disorders in women. Average time from symptom onset to diagnosis: 14 to 16 years. For men: approximately two years.
The gap exists because bleeding disorders were historically studied in male patients. Women present differently. Heavy menstrual bleeding — affecting up to one in three women with an underlying disorder — is the most common first symptom. It is also routinely dismissed as a normal variation.
The commission is calling for this gap to be reduced to under two years by 2035. That requires point-of-care change: gynecologists, who see these patients first, need to be screening for bleeding disorders as part of the workup for menorrhagia.
The downstream costs of the current gap include unnecessary procedures, undertreated anemia, and preventable hemorrhage during childbirth and surgery.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?